| LFM-A13 |
ENSG00000088970.11 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000104691.10 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000104691.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000118412.8 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000118412.8 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000135253.9 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000146666.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000157306.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000164621.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000172965.10 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000173867.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000174403.11 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000175701.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000175773.8 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000176728.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000177337.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000178803.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000179935.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000180846.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000181097.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000182109.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000182648.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000182873.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000182873.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000183535.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000185044.10 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000185186.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000186019.10 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000186369.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000186842.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000188206.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000188365.3 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000189223.9 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000196421.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000196668.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000196696.8 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000196756.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000197291.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000197670.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000203288.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000203335.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000203356.2 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000203386.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000203709.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000203865.5 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000203987.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000204055.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000204091.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000204241.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000204380.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000204802.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000204832.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000204934.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000205424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000205628.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000205885.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000205890.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000206195.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000212694.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000213971.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000213981.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000214184.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000214725.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000214725.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000214733.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000214770.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000214894.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000215244.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000215386.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000215394.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000215424.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000215447.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000215769.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000215841.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000215859.4 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000215863.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000215908.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000220161.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000220925.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000223356.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000223379.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000223380.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000223380.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000223393.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000223442.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000223442.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000223462.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000223486.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000223571.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000223652.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000223697.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000223764.2 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000223768.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000223779.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000223797.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000223804.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000223804.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000223813.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000223813.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000223842.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000223855.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000223907.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000223956.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000224020.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000224031.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000224078.8 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000224100.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000224142.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000224216.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000224272.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000224356.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000224376.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000224387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000224394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000224409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000224490.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000224490.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000224533.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000224574.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000224592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000224616.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000224635.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000224648.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000224660.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000224660.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000224660.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000224671.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000224713.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000224733.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000224761.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000224789.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000224804.4 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000224818.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000224844.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000224849.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000224883.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000224888.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000224899.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000224969.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000224992.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000225030.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000225083.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000225111.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000225146.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000225163.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000225177.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000225180.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000225205.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000225210.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000225285.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000225311.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000225331.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000225331.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000225378.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000225439.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000225442.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000225489.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000225555.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000225572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000225760.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000225778.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000225891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000225930.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000225945.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000225953.2 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000226009.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000226067.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000226067.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000226087.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000226091.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000226091.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000226155.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000226245.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000226263.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000226308.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000226312.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000226352.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000226381.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000226390.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000226526.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000226548.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000226571.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000226637.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000226648.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000226659.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000226661.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000226699.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000226702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000226711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000226751.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000226803.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000226833.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000226890.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000226891.2 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000226953.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000226954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000227006.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000227017.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000227098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000227248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000227253.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000227285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000227290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000227400.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000227403.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000227409.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000227432.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000227484.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000227486.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000227487.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000227495.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000227543.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000227603.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000227676.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000227678.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000227695.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000227698.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000227702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000227704.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000227704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000227773.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000227888.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000227896.2 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000227953.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000227953.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000227959.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000228010.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000228028.2 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000228107.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000228107.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000228107.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000228109.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000228113.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000228137.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000228140.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000228141.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000228261.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000228274.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000228294.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000228317.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000228369.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000228372.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000228386.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000228412.2 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000228414.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000228444.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000228486.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000228487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000228495.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000228677.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000228719.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000228737.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000228793.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000228794.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000228798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000228802.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000228809.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000228812.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000228838.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000228906.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000228973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000229017.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000229036.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000229056.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000229152.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000229152.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000229178.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000229180.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000229195.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000229214.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000229325.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000229331.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000229380.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000229388.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000229393.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000229404.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000229431.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000229444.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000229502.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000229521.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000229536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000229625.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000229692.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000229727.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000229841.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000229867.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000229869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000229891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000229931.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000229951.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000229955.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000229955.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000229964.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000230084.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000230105.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000230131.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000230303.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000230319.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000230319.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000230333.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000230479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000230489.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000230530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000230530.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000230552.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000230612.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000230613.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000230735.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000230736.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000230747.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000230798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000230850.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000230850.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000230880.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000230912.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000230922.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000230940.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000231010.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000231010.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000231010.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000231024.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000231028.4 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000231074.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000231104.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000231104.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000231125.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000231128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000231154.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000231196.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000231227.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000231273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000231305.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000231312.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000231437.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000231439.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000231566.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000231607.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000231638.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000231651.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000231764.4 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000231840.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000231842.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000231856.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000231856.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000231871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000231881.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000231889.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000231920.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000231992.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000232002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000232044.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000232093.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000232117.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000232160.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000232224.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000232274.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000232336.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000232352.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000232363.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000232377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000232386.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000232401.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000232487.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000232504.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000232611.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000232613.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000232613.2 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000232640.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000232710.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000232725.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000232725.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000232732.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000232754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000232756.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000232855.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000232860.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000232931.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000232969.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000232973.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000233006.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000233006.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000233013.4 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000233056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000233068.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000233108.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000233137.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000233144.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000233178.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000233303.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000233303.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000233303.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000233334.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000233360.4 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000233368.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000233429.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000233554.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000233602.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000233613.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000233635.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000233642.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000233757.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000233800.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000233806.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000233818.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000233818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000233885.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000233885.3 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000233901.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000233906.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000234006.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000234050.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000234062.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000234134.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000234156.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000234185.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000234206.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000234230.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000234232.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000234252.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000234281.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000234350.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000234405.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000234423.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000234423.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000234535.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000234610.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000234630.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000234676.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000234678.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000234694.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000234754.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000234773.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000234793.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000234807.4 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000234848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000234860.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000234871.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000234880.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000234913.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000234921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000234936.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000234996.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000234997.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000235005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000235021.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000235027.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000235072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000235100.3 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000235117.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000235126.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000235159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000235192.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000235192.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000235214.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000235215.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000235244.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000235257.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000235257.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000235313.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000235358.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000235373.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000235398.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000235408.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000235475.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000235481.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000235499.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000235527.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000235586.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000235590.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000235659.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000235663.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000235724.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000235726.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000235772.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000235777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000235790.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000235806.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000235831.2 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000235908.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000235910.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000235954.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000235958.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000235999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000236016.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000236017.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000236051.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000236066.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000236144.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000236188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000236197.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000236199.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000236213.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000236255.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000236266.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000236384.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000236426.3 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000236472.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000236498.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000236498.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000236540.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000236545.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000236558.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000236591.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000236617.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000236617.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000236617.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000236668.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000236682.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000236703.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000236711.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000236751.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000236753.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000236871.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000236889.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000236896.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000236901.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000236908.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000236943.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000236953.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000236977.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000236991.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000237021.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000237021.2 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000237037.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000237119.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000237125.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000237133.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000237200.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000237234.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000237250.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000237265.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000237291.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000237343.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000237357.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000237371.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000237424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000237438.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000237457.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000237461.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000237471.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000237502.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000237502.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000237505.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000237517.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000237520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000237523.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000237543.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000237637.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000237685.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000237768.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000237775.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000237781.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000237807.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000237851.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000237852.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000237899.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000237928.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000237934.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000237940.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000237976.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000238005.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000238018.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000238039.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000238042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000238045.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000238057.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000238058.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000238062.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000238107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000238123.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000238133.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000238141.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000238160.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000238261.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000238273.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000239608.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000239636.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000239664.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000239674.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000239774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000239994.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000240015.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000240086.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000240211.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000240211.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000240288.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000240291.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000240401.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000240498.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000240541.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000240549.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000240549.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000240618.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000240661.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000240710.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000240758.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000240770.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000240907.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000241014.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000241054.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000241163.3 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000241169.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000241316.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000241449.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000241505.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000241520.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000241570.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000241679.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000241720.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000241769.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000241769.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000241818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000241860.2 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000241884.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000241886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000241954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000241954.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000242086.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000242125.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000242207.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000242282.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000242349.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000242553.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000242622.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000242686.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000242687.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000242687.2 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000242861.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000242902.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000243144.2 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000243193.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000243230.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000243230.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000243243.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000243415.2 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000243433.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000243485.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000243533.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000243797.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000243810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000244063.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000244124.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000244161.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000244198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000244265.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000244268.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000244306.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000244327.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000244332.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000244479.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000244733.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000244945.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000245112.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000245149.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000245275.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000245293.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000245466.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000245532.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000245532.4 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000245598.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000245694.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000245711.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000245729.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000245857.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000246174.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000246228.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000246308.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000246451.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000246548.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000246740.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000246851.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000247137.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000247516.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000247516.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000247624.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000247679.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000247679.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000247735.2 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000247765.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000247796.2 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000247809.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000247853.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000247925.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000247934.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000248100.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000248125.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000248131.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000248202.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000248243.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000248243.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000248243.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000248265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000248356.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000248399.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000248416.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000248476.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000248479.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000248494.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000248664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000248671.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000248693.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000248714.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000248774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000248846.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000248846.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000248925.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000248973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000248994.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000249001.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000249035.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000249084.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000249241.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000249249.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000249412.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000249417.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000249430.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000249509.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000249604.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000249641.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000249664.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000249684.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000249846.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000249846.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000249868.4 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000250012.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000250012.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000250046.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000250056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000250072.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000250101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000250116.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000250122.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000250155.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000250156.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000250282.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000250326.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000250366.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000250397.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000250410.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000250432.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000250447.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000250451.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000250508.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000250608.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000250659.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000250659.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000250699.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000250742.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000250742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000250802.2 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000250802.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000250846.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000250903.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000250909.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000250909.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000251003.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000251018.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000251136.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000251143.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000251168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000251169.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000251330.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000251387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000251408.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000251497.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000251600.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000251666.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000251666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000251867.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000253125.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000253133.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000253174.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000253174.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000253187.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000253347.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000253357.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000253513.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000253641.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000253669.3 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000253671.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000253678.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000253687.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000253716.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000253744.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000253774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000253829.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000253844.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000253875.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000253893.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000253972.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000253978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000253982.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000254003.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000254003.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000254034.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000254057.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000254142.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000254144.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000254207.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000254233.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000254266.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000254267.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000254317.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000254337.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000254340.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000254341.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000254370.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000254414.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000254419.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000254427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000254433.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000254461.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000254461.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000254510.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000254533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000254556.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000254566.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000254602.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000254604.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000254615.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000254631.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000254638.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000254676.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000254689.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000254718.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000254733.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000254757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000254777.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000254812.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000254839.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000254839.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000254859.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000254862.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000254878.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000254900.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000254936.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000254990.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000255032.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000255045.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000255081.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000255118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000255121.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000255176.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000255229.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000255236.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000255237.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000255241.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000255250.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000255306.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000255308.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000255310.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000255322.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000255343.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000255367.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000255375.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000255422.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000255428.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000255435.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000255521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000255571.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000255669.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000255741.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000255741.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000255843.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000256050.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000256083.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000256139.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000256150.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000256250.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000256433.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000256442.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000256442.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000256481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000256546.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000256588.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000256603.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000256690.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000256712.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000256757.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000256757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000256802.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000256824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000256967.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000256967.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000257052.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000257056.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000257058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000257058.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000257084.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000257151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000257202.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000257226.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000257252.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000257256.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000257270.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000257272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000257410.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000257433.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000257467.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000257475.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000257496.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000257497.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000257507.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000257507.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000257509.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000257595.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000257605.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000257605.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000257636.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000257647.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000257702.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000257732.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000257742.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000257829.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000257910.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000257964.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000258017.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000258082.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000258096.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000258101.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000258136.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000258199.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000258260.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000258314.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000258323.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000258323.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000258378.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000258378.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000258428.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000258515.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000258520.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000258520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000258525.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000258525.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000258526.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000258534.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000258593.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000258602.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000258658.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000258673.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000258682.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000258704.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000258735.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000258760.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000258825.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000258857.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000258891.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000258902.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000258903.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000258904.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000258914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000258926.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000258929.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000258935.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000258935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000258935.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000258955.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000258959.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000258983.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000258999.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000259002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259005.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000259031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259038.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000259038.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000259038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259054.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000259055.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259093.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000259138.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000259158.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000259212.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000259230.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259244.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000259244.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000259244.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000259248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000259287.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000259296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259310.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000259327.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000259327.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259336.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000259343.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000259366.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000259372.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000259380.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000259408.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000259416.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000259417.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000259417.2 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000259417.2 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000259445.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000259453.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000259462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259488.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000259523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259551.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000259553.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259561.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259575.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000259594.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000259595.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000259635.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000259644.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000259644.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000259654.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000259656.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000259659.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000259663.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259668.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000259673.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000259701.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000259705.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259719.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259723.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000259760.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000259762.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000259763.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259782.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000259782.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000259783.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000259792.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000259810.2 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000259820.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000259834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259843.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259867.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000259869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259883.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000259886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259894.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000259920.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000259921.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000259953.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000259954.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000259954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259967.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000259969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000259972.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000259999.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000260000.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000260005.2 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000260005.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000260006.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000260011.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260025.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000260030.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260038.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000260038.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000260059.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000260093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260176.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000260190.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000260198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260257.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000260257.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000260296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260336.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000260352.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260367.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000260368.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000260369.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260441.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000260464.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000260469.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260470.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260493.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000260526.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000260528.2 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000260536.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000260536.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000260558.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000260578.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260604.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000260608.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260614.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260618.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000260641.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000260645.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000260655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260657.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000260671.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000260698.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000260743.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260750.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000260787.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000260796.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000260807.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260808.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000260830.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000260830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260831.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000260831.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260853.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000260855.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260877.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000260891.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000260910.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000260931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260941.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000260948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000260979.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000261024.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261068.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000261069.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261083.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000261096.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000261101.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000261117.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000261124.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000261141.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000261168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261172.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000261186.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261204.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000261252.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000261253.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261286.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000261288.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000261291.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000261305.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000261329.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000261342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261384.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261423.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000261428.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000261430.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000261435.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261447.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261488.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000261490.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000261512.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261529.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000261529.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000261533.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000261541.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000261542.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000261574.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000261589.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000261596.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000261596.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000261613.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000261613.2 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000261632.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000261685.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261690.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000261723.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000261731.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000261757.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000261766.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000261786.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000261797.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261798.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000261799.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000261823.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261824.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000261829.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000261971.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000262074.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000262089.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000262115.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000262152.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000262228.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000262265.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000262298.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000262434.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000262468.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000262482.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000262693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000262768.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000262772.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000262772.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000262777.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000262877.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000262903.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000262905.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000262921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000262951.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000262979.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000263015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000263098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000263214.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000263220.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000263244.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000263272.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000263272.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000263293.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000263345.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000263370.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000263470.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000263499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000263531.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000263624.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000263683.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000263709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000263717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000263860.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000263862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000263916.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000263924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000263934.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000263938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000264188.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000264304.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000264304.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000264365.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000264365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000264448.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000264448.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000264520.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000264575.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000264672.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000264808.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000264932.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000265010.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000265043.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000265091.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000265130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000265148.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000265349.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000265394.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000265458.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000265474.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000265487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000265496.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000265542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000265656.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000265666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000265688.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000265801.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000265845.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000266088.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000266126.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000266236.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000266256.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000266290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000266312.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000266340.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000266401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000266446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000266456.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000266466.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000266469.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000266473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000266521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000266538.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000266578.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000266664.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000266667.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000266801.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000266824.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000266844.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000266896.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000266897.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000266912.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000266912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000266918.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000266927.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000266927.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000266942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000266955.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000266999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000267009.2 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000267016.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000267018.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000267034.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000267044.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000267073.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000267095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000267096.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000267108.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000267118.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000267130.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000267141.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000267161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000267194.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000267194.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000267197.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000267197.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000267231.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000267232.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000267248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000267251.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000267263.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000267265.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000267273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000267298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000267302.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000267321.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000267342.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000267381.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000267395.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000267397.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000267424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000267521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000267530.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000267568.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000267575.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000267644.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000267667.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000267729.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000267731.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000267737.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000267765.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000267776.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000267783.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000267834.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000267874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000267927.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000267940.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000267940.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000268056.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000268056.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000268093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000268095.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000268201.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000268231.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000268262.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000268289.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000268307.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000268375.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000268392.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000268401.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000268499.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000268499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000268543.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000268549.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000268564.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000268583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000268613.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000268670.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000268670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000268764.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000268895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000268912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000268938.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000268938.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000268945.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000268947.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000268947.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000269054.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000269102.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000269107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000269161.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000269161.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000269191.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000269194.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000269365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000269386.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000269425.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000269463.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000269473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000269480.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000269560.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000269574.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000269609.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000269653.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000269680.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000269694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000269752.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000269836.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000269836.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000269892.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000269893.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000269894.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000269895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000269896.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000269899.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000269918.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000269942.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000269942.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000269958.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000269973.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000269974.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000269997.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000269997.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000269997.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000270019.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000270028.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000270035.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000270039.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000270048.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000270050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000270061.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000270061.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000270067.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000270069.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000270074.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000270076.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000270083.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000270102.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000270104.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000270104.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000270109.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000270124.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000270130.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000270130.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000270157.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000270171.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000270173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000270184.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000270189.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000270190.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000270223.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000270237.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000270246.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000270426.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000270557.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000270599.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000270704.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000270726.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000270761.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000270949.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000270988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000270996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000271020.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000271032.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000271086.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000271086.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000271200.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000271218.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000271218.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000271259.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000271270.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000271324.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000271347.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000271347.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000271366.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000271420.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000271555.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000271576.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000271590.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000271643.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000271716.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000271722.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000271738.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000271755.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000271755.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000271757.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000271757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000271771.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000271803.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000271815.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000271830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000271840.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000271857.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000271871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000271882.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000271912.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000271913.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000271916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000271948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000271963.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000271966.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000271967.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000271983.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000271997.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000272002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272072.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000272077.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000272077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272086.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000272087.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000272097.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000272121.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000272123.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000272130.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000272141.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000272143.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000272181.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000272209.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000272211.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000272216.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000272217.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272226.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000272240.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000272248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272275.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000272301.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000272301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272320.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000272328.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000272341.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000272369.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272375.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272417.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000272417.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000272425.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272432.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000272452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272462.2 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000272468.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000272468.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000272473.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000272489.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000272506.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272523.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000272556.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000272562.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272610.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000272627.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272630.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000272631.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000272635.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000272644.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000272645.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000272646.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000272688.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000272702.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000272717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272719.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000272733.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000272733.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272735.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000272744.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000272744.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272758.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000272763.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272782.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000272798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| LFM-A13 |
ENSG00000272808.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000272824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272832.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000272836.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000272846.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272849.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272858.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000272872.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000272872.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272913.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000272931.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000272931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272945.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000272949.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000272950.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000272966.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000272977.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000273004.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000273009.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000273017.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000273027.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000273056.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000273065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000273066.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000273081.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000273091.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000273096.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000273102.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000273104.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000273116.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000273123.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000273137.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000273142.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000273148.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000273156.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000273176.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000273188.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000273188.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000273203.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000273230.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000273237.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| LFM-A13 |
ENSG00000273271.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000273271.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000273287.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000273293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000273302.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| LFM-A13 |
ENSG00000273302.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000273308.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000273321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000273325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000273343.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000273365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000273372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000273373.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000273424.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| LFM-A13 |
ENSG00000273428.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000273442.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000273442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| LFM-A13 |
ENSG00000273447.1 |
Predicted lncRNA |
Esophageal cancer |
|
| LFM-A13 |
ENSG00000273449.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| LFM-A13 |
ENSG00000273472.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000273474.1 |
Predicted lncRNA |
Sarcoma |
|
| LFM-A13 |
ENSG00000273483.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| LFM-A13 |
ENSG00000273483.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
